Lingli Chen

6.0k citations

103 papers · 4.0k indexed · 3 hit papers · h-index 32

Impact in

Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in ⓘ

Hepatology 15
- Hepatocellular Carcinoma Treatment and Prognosis 13
Oncology 30
- Cancer Immunotherapy and Biomarkers 9

Co-authors: Yaping Li (13 shared papers)Haijun Yu (11 shared papers)Qi Yin (9 shared papers)Wangwen Gu (11 shared papers)Zhiwen Zhang (10 shared papers)Qingshuo Meng (7 shared papers)Jinghan Su (6 shared papers)Huiping Sun (5 shared papers)
Journals: Advanced Functional Materials (5 papers)Abdominal Radiology (3 papers)Cancer Management and Research (3 papers)Histopathology (2 papers)IEEE Electron Device Letters (2 papers)
Partner nations: China United States Australia

In The Last Decade

Lingli Chen

97 papers receiving 3.9k citations

Hit Papers

align trajectories log scale

The Interaction between Flavonoids and Intestinal Microbes: A Review 2023 · 105 citations

Peers

Countries citing papers authored by Lingli Chen

Since Specialization

Citations

This map shows the geographic impact of Lingli Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingli Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingli Chen more than expected).

Fields of papers citing papers by Lingli Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingli Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingli Chen. The network helps show where Lingli Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Lingli Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lingli Chen Line = papers co-authored together Lingli Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cancer‐Cell‐Biomimetic Nanoparticles for Targeted Therapy of Homotypic Tumors Advanced Materials ·Huiping Sun, Jinghan Su, Qingshuo Meng, Qi Yin, Lingli Chen, Wangwen Gu, Pengcheng Zhang, Zhiwen Zhang, Haijun Yu, Siling Wang, Yaping Li Hit paper breakdown →	2016	540
2	Cancer Cell Membrane-Coated Gold Nanocages with Hyperthermia-Triggered Drug Release and Homotypic Target Inhibit Growth and Metastasis of Breast Cancer Advanced Functional Materials ·Huiping Sun, Jinghan Su, Qingshuo Meng, Qi Yin, Lingli Chen, Wangwen Gu, Zhiwen Zhang, Haijun Yu, Pengcheng Zhang, Siling Wang, Yaping Li	2016	318
3	Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer Gut ·Chao Lin, Hongyong He, Hao Liu, Ruochen Li, Yifan Chen, Yangyang Qi, Qi Jiang, Lingli Chen, Peipei Zhang, Heng Zhang, He Li, Weijuan Zhang, Yihong Sun, Jiejie Xu	2019	283
4	A Microbiota-Derived Bacteriocin Targets the Host to Confer Diarrhea Resistance in Early-Weaned Piglets Cell Host & Microbe ·Jun Hu, Libao Ma, Yangfan Nie, Jianwei Chen, Wenyong Zheng, Xinkai Wang, Chunlin Xie, Zilong Zheng, Zhichang Wang, Tao Yang, Min Shi, Lingli Chen, Qiliang Hou, Yaorong Niu, Xiaofan Xu, Yuhua Zhu, Yong Zhang, Hong Wei, Xianghua Yan	2018	214
5	Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin Nature Cell Biology ·Lihua Min, Yuan Ji, Latifa Bakiri, Zhixin Qiu, Jin Cen, Xiaotao Chen, Lingli Chen, Harald Scheuch, Hai Zheng, Lun–Xiu Qin, Kurt Zatloukal, Lijian Hui, Erwin F. Wagner	2012	195
6	Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations Liver Cancer ·Xiao‐Dong Zhu, Cheng Huang, Ying‐Hao Shen, Yuan Ji, Ningling Ge, Xu-Dong Qu, Lingli Chen, Wen-Kai Shi, Meiling Li, Jinjin Zhu, Chang‐Jun Tan, Zhao–You Tang, Jian Zhou, Jia Fan, Hui‐Chuan Sun Hit paper breakdown →	2021	159
7	Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel Biomaterials ·Shan Tang, Qi Yin, Jinghan Su, Huiping Sun, Qingshuo Meng, Yi Chen, Lingli Chen, Yongzhuo Huang, Wangwen Gu, Ming‐Hua Xu, Haijun Yu, Zhiwen Zhang, Yaping Li	2015	128
8	Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma BMC Cancer ·Min Du, Lingli Chen, Jing Zhao, Feng Tian, Haiying Zeng, Yun-shan Tan, Hui‐Chuan Sun, Jian Zhou, Yuan Ji	2014	111
9	Tumor‐Penetrating Nanotherapeutics Loading a Near‐Infrared Probe Inhibit Growth and Metastasis of Breast Cancer Advanced Functional Materials ·Xinyu He, Xiaoyue Bao, Haiqiang Cao, Zhiwen Zhang, Qi Yin, Wangwen Gu, Lingli Chen, Haijun Yu, Yaping Li	2015	107
10	The Interaction between Flavonoids and Intestinal Microbes: A Review Foods ·Huihui Xiong, Su-Yun Lin, Lingli Chen, Kehui Ouyang, Wenjun Wang Hit paper breakdown →	2023	105
11	Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS International Journal of Pharmaceutics ·Pengfei Xu, Qi Yin, Jianan Shen, Lingli Chen, Haijun Yu, Zhiwen Zhang, Yaping Li	2013	97
12	Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients—A single institution retrospective study of 292 lung adenocarcinoma Journal of Surgical Oncology ·Jie Gu, Chunlai Lu, Jing Guo, Lingli Chen, Yiwei Chu, Yuan Ji, Di Ge	2012	96
13	Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers Genome Medicine ·Jinming Cheng, Dongkai Wei, Yuan Ji, Lingli Chen, Liguang Yang, Guang Li, Leilei Wu, Ting Hou, Lu Xie, Guohui Ding, Hong Li, Yixue Li	2018	93
14	Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression Journal of Controlled Release ·Haiqiang Cao, Zhiwen Zhang, Shuang Zhao, Xinyu He, Haijun Yu, Yin Qi, Zhiping Zhang, Wangwen Gu, Lingli Chen, Yaping Li	2015	88
15	Tumor‐Microenvironment‐Adaptive Nanoparticles Codeliver Paclitaxel and siRNA to Inhibit Growth and Lung Metastasis of Breast Cancer Advanced Functional Materials ·Shan Tang, Qingshuo Meng, Huiping Sun, Jinghan Su, Qi Yin, Zhiwen Zhang, Haijun Yu, Lingli Chen, Yi Chen, Wangwen Gu, Yaping Li	2016	87
16	Mangiferin prevents myocardial infarction‐induced apoptosis and heart failure in mice by activating the Sirt1/FoxO3a pathway Journal of Cellular and Molecular Medicine ·Lingli Chen, Santie Li, Jianyu Zhu, Anfu You, Xingzhou Huang, Xinchu Yi, Mei Xue	2021	78
17	Lactobacillus frumenti Facilitates Intestinal Epithelial Barrier Function Maintenance in Early-Weaned Piglets Frontiers in Microbiology ·Jun Hu, Lingli Chen, Wenyong Zheng, Min Shi, Liu Liu, Chunlin Xie, Xinkai Wang, Yaorong Niu, Qiliang Hou, Xiaofan Xu, Baoyang Xu, Yimei Tang, Shuyi Zhou, Yiqin Yan, Tao Yang, Libao Ma, Xianghua Yan	2018	62
18	Highly Effective Colorimetric and Visual Detection of ATP by a DNAzyme–Aptamer Sensor Chemistry & Biodiversity ·Fang Liu, Juan Zhang, Rong Chen, Lingli Chen, Le Deng	2011	61
19	Induction of apoptosis in non-small cell lung cancer by downregulation of MDM2 using pH-responsive PMPC-b-PDPA/siRNA complex nanoparticles Biomaterials ·Haijun Yu, Yonglong Zou, Lei Jiang, Qi Yin, Xinyu He, Lingli Chen, Zhiwen Zhang, Wangwen Gu, Yaping Li	2013	58
20	Age at menarche and risk of major cardiovascular diseases: Evidence of birth cohort effects from a prospective study of 300,000 Chinese women International Journal of Cardiology ·Ling Yang, Liming Li, Iona Y. Millwood, Sanne A. E. Peters, Yiping Chen, Canqing Yu, Zheng Bian, Xiaofang Chen, Lingli Chen, Shixian Feng, Jun Lv, Zhigang Pang, Mark Woodward, Zhengming Chen	2016	49

About Lingli Chen

Lingli Chen is a scholar working on Hepatology, Oncology, Internal Medicine, Cancer Research and Biomaterials, having authored 103 papers that have together received 4.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers), Nanoparticle-Based Drug Delivery (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Nanoplatforms for cancer theranostics (8 papers), Neuroendocrine Tumor Research Advances (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Biomaterials (765 citations), Hepatology (439 citations), Geriatrics and Gerontology (115 citations), Oncology (772 citations) and Cancer Research (420 citations). Lingli Chen has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yaping Li, Haijun Yu, Qi Yin, Wangwen Gu, Zhiwen Zhang, Qingshuo Meng, Jinghan Su, Huiping Sun, Pengcheng Zhang and Yuan Ji. Their work appears in journals such as Advanced Functional Materials, Abdominal Radiology, Cancer Management and Research, Histopathology and IEEE Electron Device Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact